Gangliosides and Autoimmune Peripheral Nerve Diseases

Area of Science:

• Neuroimmunology
• Peripheral Nervous System (PNS) Disorders
• Glycobiology

Background:

• Autoimmune neuropathies are a group of neuroimmunological diseases affecting the peripheral nervous system.
• These conditions are mediated by antibodies targeting specific glycolipids, particularly gangliosides, found in nerve compartments.
• Gangliosides are crucial for PNS structure and function, and their autoimmune targeting leads to nerve damage.

Purpose of the Study:

• To review the immunological, pathological, and clinical features of autoimmune neuropathies.
• To explore the role of gangliosides and antiganglioside antibodies in these disorders.
• To discuss the mechanisms of antibody induction, including molecular mimicry and natural autoantibody production.

Main Methods:

• Literature review of autoimmune neuropathies, focusing on antiganglioside antibodies.
• Analysis of the relationship between infections (e.g., Campylobacter jejuni) and antibody development.
• Examination of antibody targets including gangliosides (GM1, GD1a, GT1a) and myelin-associated glycoprotein (MAG).

Main Results:

• Antiganglioside antibodies are linked to Guillain-Barré syndrome and chronic autoimmune neuropathies.
• Infections like Campylobacter jejuni can induce antibodies via molecular mimicry, targeting ganglioside-like structures.
• Naturally occurring antibodies and anti-MAG antibodies contribute to distinct neuropathy syndromes.

Conclusions:

• Autoimmune neuropathies result from antibodies targeting peripheral nerve gangliosides and related epitopes.
• Understanding ganglioside glycobiology is key to comprehending the pathogenesis of these nerve diseases.
• The review synthesizes current knowledge on the immunological triggers, pathological consequences, and clinical presentations of these disorders.